Page last updated: 2024-10-23

bml 190 and Nerve Degeneration

bml 190 has been researched along with Nerve Degeneration in 1 studies

indomethacin morpholinylamide: an inverse agonist of the cannabinoid CB2 receptor

Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.

Research Excerpts

ExcerptRelevanceReference
" 2 Delta(9)-and Delta(8)-tetrahydrocannabinol (THC) were toxic when added directly to SH-SY5Y neuroblastoma cells."1.32Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. ( Bissonnette, CJ; Klegeris, A; McGeer, PL, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klegeris, A1
Bissonnette, CJ1
McGeer, PL1

Other Studies

1 other study available for bml 190 and Nerve Degeneration

ArticleYear
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.
    British journal of pharmacology, 2003, Volume: 139, Issue:4

    Topics: Astrocytes; Camphanes; Cannabinoid Receptor Modulators; Cannabinoids; Cell Line; Cytokines; Dronabin

2003